baber/WOPTO huggingface dataset:
Patent NZ-540694-A (NZ)
Title: Novel aromatic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof
Inventor: FRICK WENDELIN
Filed: 2003-11-28
Abstract: Disclosed are fluoroglycoside derivatives of formula 1 wherein the substituents are as described in the specification. Compounds of the type disclosed are useful in lowering blood glucose and in preventing and treating type 1 and type 2 diabetes.
Patent NZ-541850-A (NZ)
Title: Email encryption method and system
Inventor: MILLER RONALD WARREN
Filed: 2005-08-17
Abstract: An apparatus for sending email is disclosed. The apparatus comprises an encryption policy database for storing encryption policies pertaining to possible addressees, and a mail mediator for intercepting an email message after being dispatched by a mail user agent. The mail mediator is configured to retrieve any encryption policy pertaining to the addressee from the encryption policy database and to apply the encryption policy to the email message. The mail mediator attempts to encrypt the email message if the encryption policy pertaining to the addressee dictates that the email message should be encrypted.
Patent NZ-545717-A (NZ)
Title: Hydrogenated quinazoline derivatives as inhibitors of voltage-gated ion channels
Inventor: WANG JIAN
IPC: A61K31/5377
Filed: 2004-08-05
Abstract: Disclosed are hydrogenated quinazoline derivatives of formula I-B; or a pharmaceutically acceptable salt thereof, wherein R1 is hydrogen, methyl, ethyl, or benzyl, and R2 is methyl, ethyl, dimethylaminoethyl, 2-(2'-tetrahydrofuranyl)methyl, 2-hydroxy-1-methyl-ethyl, methylaminoethyl, imidazol-5-yl-ethyl, or R1 and R2 taken together form 4-methoxypiperidinyl, N-pyrrolidinyl, 3-trifluoromethyl-1-pyrrolidinyl, 4-butylsulfonyl-piperazinyl, 1-piperidinyl, 1-piperazinyl, 4-methylpiperidinyl, 4-hydroxypiperidinyl, 4-morpholinyl, 4-methylsulfonylpiperazinyl, 4-ethylsulfonylpiperazinyI, 4-isopropylsulfonylpiperazinyI, N-piperidinyl, 3-diethylaminocarbonyl-1-piperidinyI, 4-oxo-piperidinyI, 3-aminocarbonyl-piperidinyl, 4-methylpiperazinyl, or 4-carboxyethyl-piperazinyI; ring A is 1-pyrrolyl, 2-pyridyl, 2-fluorophenyl, 2-hydroxyphenyl, 2-acyloxyphenyl, 2-hydroxy-6-fluorophenyl, 2-methoxyphenyl, phenyl-2-phosphate disodium salt, or 4-methylpiperidyl, 2-ethylcarbamic acid phenyl ester; x is 1 and R4 is 6-methyl, 7-methyI or 8-hydroxy. The use of a compound as defined above for the manufacture of a medicament for treating or lessening the severity of a disease, disorder, or conditions such as acute, chronic, neuropathic, or inflammatory pain is further disclosed.
Patent NZ-546439-A (NZ)
Title: Method for preparing submicron particles of paclitaxel
Inventor: CHAUBAL MAHESH
IPC: A61K31/12
Filed: 2004-11-03
Abstract: Disclosed is a method for preparing a pharmaceutical composition of submicron particles of precipitated paclitaxel or its derivative compounds, the solubility of which is greater in a water miscible first solvent than in a second solvent that is aqueous, the method comprising the steps of: (i) mixing into the water-miscible first solvent or the second solvent or both the water miscible first solvent and the second solvent, a first surface modifier comprising a phospholipid conjugated with a water-soluble or hydrophilic polymer; (ii) mixing into the water-miscible first solvent or the second solvent or both the water miscible first solvent and the second solvent, a second surface modifier selected from the group consisting of: anionic surfactants, cationic surfactants, non ionic surfactants and surface active biological modifiers; (iii) dissolving paclitaxel or its derivative compounds in the water-miscible first solvent to form a solution; (iv) mixing the solution with the second solvent to define a pre-suspension of particles; and (v) homogenizing the pre-suspension to form a suspension of precipitated small particles having an average effective particle size of less than about 1000 nanometres. Also disclosed is a composition of submicron particles of precipitated paclitaxel or its derivative compounds prepared by said method.
Patent NZ-546934-A (NZ)
Title: Method and system for injecting a treatment fluid into a well
Inventor: VAN ELJDEN GERBRAND JOZEF MARIA
IPC: E21B37/06
Filed: 2004-11-05
Abstract: A system for injecting a treatment fluid into a well comprising a surface controlled subsurface safety valve 5, which is controlled by varying fluid pressure in a valve control conduit 8 which extends from the safety valve 5 to a wellhead of the well, the system comprising a valve control conduit 8 and at least one treatment fluid injection opening for discharging treatment fluid into the well; and which system further comprises a treatment fluid-injection conduit 12 for injecting treatment fluid into the well, which treatment fluid injection conduit 12 is connected to the valve control conduit 8, and which treatment fluid injection conduit 12 comprises the at least one treatment fluid injection opening and a one way check valve 13 which prevents fluid flow from each treatment fluid injection opening via the treatment fluid injection conduit 12 into the valve control conduit 8, wherein the treatment fluid injection conduit is arranged to extend into a section of the well which is located below the safety valve 5 such that at least one treatment fluid injection opening is located below the safety valve 5.
Patent NZ-547119-A (NZ)
Title: Catalytic calcination process for making rutile pigments from aqueous titanium solutions
Inventor: PROCHAZKA JAN
IPC: C09C1/36
Filed: 2004-11-10
Abstract: A low-temperature process for producing pigment-grade rutile titanium dioxide from an aqueous solution is disclosed, wherein the process comprises the following sequential steps: (a) preparing an aqueous feed solution comprising one or more titanium compounds; (b) adding a catalyzing salt selected from the group of alkali metal salts to the solution in an amount from 3 weight % of the equivalent amount of TiO2 present in the feed solution to the amount corresponding to the saturation point of the catalyzing salt in the feed solution; (c) evaporating the solution to produce a dry amorphous intermediate that includes a mixture of titanium compounds; and (d) calcining the intermediate at a temperature less than 500 Deg C to form TiO2 rutile pigment base.
Patent NZ-550925-A (NZ)
Title: Preparation of a cabergoline polymorph using ethylbenzene
Inventor: GREENWOOD ALAN KENNETH
IPC: C07D457/06
Filed: 2005-04-29
Abstract: Disclosed is a method of preparing a polymorph of cabergoline, as described herein, comprising forming a solvate of cabergoline, ethylbenzene, and optionally n-heptane, and obtaining the polymorph by drying.
Patent NZ-556056-A (NZ)
Title: Dispensing systems
Inventor: VOK PETER GEORGE
IPC: B67D7/74
Filed: 2005-12-21
Abstract: A method of presenting content is disclosed. The method includes, in a processing system: a) determining content including schedule content and trigger content, b) determining control data for controlling the presentation of content, where the control data includes a schedule for controlling the presentation of the schedule content and indications of one or more triggers associated with the trigger content; and, c) causing the scheduled content to be presented on a display in accordance with the schedule; d) monitoring for one or more triggers; and, e) in response to the detection of a trigger interrupting the presentation of schedule content and causing trigger content associated with the respective trigger to be presented on the display.
Patent NZ-568559-A (NZ)
Title: Stretching a tubular sleeve from both ends to avoid asymmetrical expansion forces deforming the sleeve
Inventor: PORTAS FRANCESCO
IPC: B29C55/24
Filed: 2005-12-28
Abstract: A method inserting a supporting element in a tubular covering sleeve for electric-cable joints by causing radial expansion of the sleeve (2) starting from axially opposite ends (7) of the sleeve (2) itself. Stretching the sleeve (2) from both ends avoids asymmetrical expansion forces with deform the sleeve (2) and cause asymmetrical shrinking around the joint. The tubular sleeve (2) in a radially expanded condition is installed on the supporting element. An apparatus (1) for putting into practice the method comprises a support (4) for the tubular sleeve (2) and a pair of expanders (10) to be located to a position substantially coaxial with the sleeve (2), each at a respective end (7) of the sleeve (2) itself. Driving means (11) is used for introducing the expanders (10) into the respective sleeve ends (7), causing radial expansion. The apparatus (1) further comprises devices adapted to dispose the sleeve (2) in a radially expanded condition on the supporting element.
Patent NZ-576123-A (NZ)
Title: Composite light weight gypsum wallboard
Inventor: YU QIANG
IPC: B32B13/00
Filed: 2007-08-29
Abstract: Disclosed herein is a composite light weight gypsum composite board including: À- a foamed low density set gypsum core having a top surface and a bottom surface, the foamed low density set gypsum core made using a gypsum-containing slurry including stucco, pregelatinized starch, and foam, À a top non-foamed high density bonding layer having a thickness of about 2 mils to less than about 7 mils covering the top surface of the foamed low density set gypsum core, Àa bottom non-foamed high density bonding layer having a thickness of about 2 mils to less than about 7 mils covering the bottom surface of the foamed low density set gypsum core, À a top cover sheet, and À a bottom cover sheet Wherein the top cover sheet is bonded o the foamed low density set gypsum core by the top non-foamed high density bonding layer, and the bottom cover sheet is bonded to the foamed low density set gypsum core by the bottom non-foamed high density bonding layer, and wherein the composite board has a dry weight of about 1000lb/MSR or less for a ¢ inch thick board, a nail pull resistance of at least about 77lb/MSF, and a core hardness of at least about 11lb/MSF. Also disclosed are methods of making said light weight composite gypsum board using a unique gypsum-containing slurry to form a foamed low density set gypsum core and non-foamed (or reduced-foamed) bonding high density layers that bond the top and the bottom cover sheets to the core.
Patent NZ-577858-A (NZ)
Title: Method for producing novel ige based reagents
Inventor: TAKKINEN KRISTIINA
IPC: C40B50/00
Filed: 2008-01-29
Abstract: Disclosed is a method of preparing a recombinant IgE monoclonal antibody or a functional fragment thereof capable of preventing binding of a ligand or substrate to a receptor protein or enzyme, wherein the binding site of the ligand or substrate contains a depression, cleft, channel or a planar surface, and said site is weakly IgG or IgM immunoreactive, said method comprising the steps of a) isolating total mRNA from IgE producing cells from a human derived sample; b) synthesizing of the cDNAs encoding the IgE Fd gene region and kappa/lambda light chain genes based on the total mRNA obtained in step a) to create an IgE expression library; c) screening the expressed library against a desired target protein or cell or particle expressing said target protein on its surface, wherein said target protein is said receptor protein or enzyme; d) isolating clones from the library showing an affinity of at least 107M-1 towards said protein; e) selecting those clones obtained from step d) that bind to a depression, cleft, channel or a planar surface in the binding site of the ligand or substrate and prevent the binding of said ligand to said receptor protein or the binding of said substrate to said enzyme; f) optionally isolating the DNA encoding the IgE antibody obtained in step e). Further disclosed is a method of preparing a recombinant IgE monoclonal antibody or a functional fragment thereof capable of preventing binding of a protein ligand to a receptor protein, i.e. a modulator of protein-protein interactions, wherein the binding site of the protein ligand contains a planar surface, and said site is weakly IgG or IgM immunoreactive, said method comprising the steps of a) selecting a limited pool of nucleic acid sequences encoding light chains, or a nucleic acid sequence encoding single light chain, having the amino acid sequence(s) identified in the IgE antibodies; b) combining said light chain sequence(s) with a diverse pool of IgE heavy chain genes isolated from lymphocytes of several allergic patients to create an IgE expression library; c) screening the expressed library against a desired target protein or cell or particle expressing said target protein on its surface, wherein said target protein is said receptor protein; d) isolating clones from the library showing an affinity of at least 107M-1 towards said protein; e) selecting those clones obtained from step d) that bind to said planar surface in the binding site of the protein ligand and prevent the binding of said protein ligand to said receptor protein; f) optionally isolating the DNA encoding the IgE antibody obtained in step e).
Patent NZ-578981-A (NZ)
Title: Ostomy appliance including inflatable internal and external chambers with corrugated inflatable columns therebetween
Inventor: WEIG BRET
IPC: A61F5/445
Filed: 2008-02-21
Abstract: An ostomy appliance. The appliance includes an inflatable seal (20) for forming a seal at a stoma (22), the inflatable seal including: a first inflatable chamber portion (28a, 42) for insertion into the stoma for forming an internal seal; and a second inflatable chamber portion (38, 42) for forming an external seal with respect to the stoma; and a plurality of corrugated inflatable columns (46) intermediate the first and second inflatable chamber portions defining passageways for inflation fluid and pathways for escape of flatus.
Patent NZ-579939-A (NZ)
Title: Disposable injector comprising a sliding or pivoting trigger lever
Inventor: MATUSCH RUDOLF
IPC: A61M5/30
Filed: 2008-03-27
Abstract: A disposable injector with a housing (10) in which are arranged at least one mechanical spring energy store (50), at least one cylinder-piston unit that can be filled at least temporarily with an active substance, at least one piston actuation plunger (60) and at least one triggering unit (80). The spring energy store comprises at least one pre-loaded spring element. The spring-loaded piston actuation plunger has at least one traction rod which can be moved transversely, at least in certain regions, and by means of a supporting portion supports the tensioned spring energy store on at least one resting surface of the housing. An actuatable triggering slide device (82) unlocks the disposable injector and releases the supporting portion to allow it to move away from the resting surface.
Patent NZ-580373-A (NZ)
Title: Thermal cylcer system with temperature control element and a controller to control a thermostate's temperature based on a sample in a sample chamber
Inventor: SELDEN RICHARD F
IPC: B01L3/00
Filed: 2008-04-04
Abstract: Disclosed is a thermal cycler system. The system includes a temperature control element (TCE) having a first surface and a substrate comprising a sample chamber configured to contain a solution, which is positioned in thermal communication with said first surface. A sensing chamber is included which has a thermosensor, wherein the sensing chamber is fabricated to have the same material stack-up as the sample chamber, and configured and positioned so as to simulate conditions within said sample chamber. When the thermal cycler is in use there is a solution in the sample chamber. Also included is a controller configured to receive input from said thermosensor, determine the temperature of the solution in the sample chamber from said input when the thermal cycler is in use, and control heating and cooling of said first surface of said TCE to set or maintain the solution in the sample chamber at a desired temperature.
Patent NZ-583039-A (NZ)
Title: Stable pharmaceutical composition of a water-soluble vinorelbine salt
Inventor: BOUGARET JOEL
IPC: A61K9/20
Filed: 2008-07-09
Abstract: Disclosed is a stable pharmaceutical composition comprising a hydrosoluble salt of vinorelbine and at least one diluent, one lubricant, wherein said stable pharmaceutical composition is in a solid form destined for oral administration, and in that the diluent comprises a mixture of microcrystalline cellulose and a constituent chosen from D-mannitol, maize starch and dicalcium phosphate dehydrate.
Patent NZ-588322-A (NZ)
Title: Factor vii polypeptides that are modified and uses thereof
Inventor: MADISON EDWIN L
IPC: C12N9/64
Filed: 2009-04-10
Abstract: Disclosed are modified factor VII polypeptides and uses thereof. Such modified FVII polypeptides include Factor VIla and other forms of Factor VII. Among modified FVII polypeptides provided are those that have altered activities, typically altered procoagulant activity, including increased procoagulant activities. Hence, such modified polypeptides are therapeutics.
Patent NZ-589739-A (NZ)
Title: Automatic coin or electronic card operated vending washing machine and dryer for helmets
Inventor: BILIAS LOANNIS
IPC: B08B1/04
Filed: 2009-05-18
Abstract: Disclosed is an automatic coin-operated or electronic card-operated washing machine and dryer for helmets to provide improved cleaning. The device consists of a body, which is externally surrounded by a cabin, in which a washing chamber is situated. The washing chamber is the part where all cleaning operations of the helmet take place and is supplied with a gate which is connected thereto. The washing chamber is connected to a brush and spraying mechanism, a wring mechanism and a drying mechanism. A water supply pipe is connected to the machine along with a water discharge pipe, and a water supply electrical flow control valve. An instantaneous water heater heats the water to the desired washing temperature level, and a pressure water pump that, in use, increases the water pressure to the required washing level. An electrical power supply and an electric operation control system (main board) carry out a pre-programmed sequence, and a visual monitor provides indications and selection buttons. A payment card slot or a coin slot, which is placed on the cabin for the insertion of coins or prepaid card, is used to initiate the device's operation.
Patent NZ-590141-A (NZ)
Title: Anthelminthic formulations including castor oil and another vegetable oil
Inventor: RAZZAK MAJID
IPC: A01P15/00
Filed: 2009-06-24
Abstract: Disclosed is an anti-parasitic formulation comprising (a) one or more anthelmintic compounds, wherein the compound is abamectin, ivermectin, moxidectin, doramectin or eprinomectin, (b) a co-solvent present in an amount of at least 17 per cent by weight wherein the co-solvent is an alcohol having four or more carbon atoms, selected from benzyl alcohol, ethyl benzyl alcohol, phenethyl alcohol, any aromatic monohydric alcohol, and combinations thereof; (c) a castor oil present in an amount of 25 per cent by weight or less, and (d) a vegetable oil having a similar viscosity profile as compared with soya bean, sesame, or corn oil, and wherein the vegetable oil is an oil other than castor oil. The formulation can be for injection, a pour-on, or for oral administration.
Patent NZ-595468-A (NZ)
Title: Method and arrangement in a radio communications system for supporting dtx
Inventor: BALDEMAIR ROBERT
IPC: H04W36/22
Filed: 2009-05-08
Abstract: 595468 Disclosed is a user equipment (120). The user equipment (120) has an arrangement for supporting Discontinuous Transmission "DTX" and is arranged to be in a first cell (115) and is adapted to communicate over a radio carrier (125) with a first base station (110) serving the first cell (115) which is adapted to be in active mode. The user equipment (120) and the first base station (110) are in a radio communications system (100) which includes a second base station (130) adapted to serve a second cell (135) that is in a non-observable mode. The user equipment (120) arrangement includes a signalling unit configured to receive from the first base station (110), a request to perform channel sounding signalling to be observed by the second base station (130) for quality measurements. The second base station (130) has been requested by the first base station (110) to switch the second cell state from the non-observable mode to an observable mode for said user equipment (120). The signalling unit is further configured to signal channel sounding to be observed by the second base station (130) for quality measurements receives, from the first base station (110), a command to perform handover to the second cell (135). The handover command is based on quality measurement performed by the second base station (130) on the signalled channel sounding observed by the second base station (130). The user equipment arrangement also includes a performing unit configured to perform a handover from the first cell (115) to the second cell (135).
Patent NZ-596805-A (NZ)
Title: Meningococcal fHBP polypeptides
Inventor: GIULIANI MARZIA MONICA
IPC: A61K39/095
Filed: 2009-02-20
Abstract: Disclosed is a meningococcal fHBP polypeptide as defined in the specification. The disclosed polypeptide is used in the preparation of a medicament for treating or preventing meningococcal infection in a subject.
Patent NZ-598125-A (NZ)
Title: Apaf-1 inhibitor compounds
Inventor: MESSEGUER PEYPOCH ANGEL
IPC: A61K31/495
Filed: 2010-07-29
Abstract: 598125 Disclosed herein are 2,5-piperazinedione derivatives of formula (I) which inhibit apoptotic peptidase activating factor 1 (APAF-1), and consequently are useful as active pharmaceutical principles for the prophylaxis and/or treatment of a pathological and/or physiological condition associated with an increase in apoptosis. In one embodiment the derivative is 2- (4-(2,4-dichlorophenethyl)-1-(4-fluorobenzyl)-3,6-dioxopiperazin-2-yl) acetic acid.
Patent NZ-598313-A (NZ)
Title: Fluid release device and related matters
Inventor: CATE LYNN ROLAND
IPC: A23B7/144
Filed: 2012-02-21
Abstract: 598313 A gas release device (1) that includes a reservoir (3) of pressurised gas and a passageway from the reservoir to an outlet (6). There is an elastic gas permeable membrane (7) in the passageway that allows gas release only via the membrane. A gas impermeable member (8) is provided in the passageway that includes an interface positioned to contact the gas permeable membrane. Displacement of the gas permeable membrane is responsive to the pressure of the gas in the reservoir such that there is a greater interfacial contact between the gas impermeable member and the gas permeable membrane at a higher gas pressure than at lower pressure to thereby vary the exposed cross sectional area of the permeable membrane available to the flow in an inverse relationship to pressure.
Patent NZ-618222-A (NZ)
Title: Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
Inventor: JORGENSEN MORTEN
IPC: C07D241/04
Filed: 2012-06-19
Abstract: Disclosed are deuterated 1-piperazino-3-phenyl-indanes of formula Y and salts thereof with activity at dopamine receptors D1 and D2 as well as the 5HT2 receptors in the central nervous system. Also disclosed are medicaments comprising such compounds as active ingredients, the use of such compounds in the treatment of diseases in the central nervous system including schizophrenia, schizophreniform disorder, schizoaffective disorder, delusional disorder, brief psychotic disorder, shared psychotic disorder, bipolar disorder, or mania in bipolar disorder, and the use of the compounds in the manufacture of medicaments for the treatment of these conditions.